It’s mosquito season, a good reminder that even little needles can be a big pain. Imagio® features a painless, non-invasive scan to diagnose breast cancer in real-time with fewer needles. Learn more at https://lnkd.in/gUM4U9dT #BreastCancer #optoacoustic #ImagioImaging
Seno Medical
Medical Equipment Manufacturing
San Antonio, Texas 2,630 followers
Groundbreaking diagnostic imaging for breast cancer using a novel combination of ultrasound and opto-acoustic technology
About us
Seno Medical is leading commercialization efforts in opto-acoustic imaging of breast cancer. Seno’s opto-acoustic technology combines both laser optics and conventional ultrasound technology to provide fused functional and anatomical imaging in real time. The result is an imaging device that delivers additional functional information regarding breast masses and increases confidence in making a breast biopsy decision. For more information or to answer any questions call 210-615-6501 or email [email protected]. Seno’s Imagio® Breast Imaging System (9005) received the CE Mark (April 2014) and has completed a post-market surveillance and clinical follow-up study in Europe. The newest version (9100) is approved by the FDA for commercial distribution in the U.S.
- Website
-
https://senomedical.com
External link for Seno Medical
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Headquarters
- San Antonio, Texas
- Type
- Privately Held
- Founded
- 2005
- Specialties
- medical device, opto-acoustic, breast imaging, diagnostic imaging, ultrasound, and opto-acoustic imaging
Locations
-
Primary
Get directions
8023 Vantage Dr
San Antonio, Texas 78230, US
Employees at Seno Medical
-
Kari Edwards, MBA
MedTech Strategic Sales and Marketing Leader | Market Access | Capital | AI | Devices | IDN Navigator
-
Tammy García
Healthcare Executive focused on improving patient experience with disruptive new technologies.
-
Chris Oppelt
-
Craig Coggins
Medical Devices Account Executive
Updates
-
Seno Medical reposted this
Last chance to register for this webinar (Wed 7-10 9 ET) facilitated by Frost and Sullivan and Seno Medical. Join the chat and see how Seno is simplifying the Complexity of BC diagnosis.
Don’t miss it! Register now for the July 10th fireside chat with Tom Umbel, CEO, alongside market advisors from Frost & Sullivan, on Simplifying the Complexity of Diagnosing Breast Cancer, a casual discussion on the tools available to diagnose breast cancer and what is needed from technology. Sign up now at https://lnkd.in/gVKDqbTN #BreastCancer #optoacoustic #ImagioImaging
-
Last chance to register for this webinar (Wed 7-10 9 ET) facilitated by Frost and Sullivan and Seno Medical. Join the chat and see how Seno is simplifying the Complexity of BC diagnosis.
Don’t miss it! Register now for the July 10th fireside chat with Tom Umbel, CEO, alongside market advisors from Frost & Sullivan, on Simplifying the Complexity of Diagnosing Breast Cancer, a casual discussion on the tools available to diagnose breast cancer and what is needed from technology. Sign up now at https://lnkd.in/gVKDqbTN #BreastCancer #optoacoustic #ImagioImaging
-
Imagio® can reduce the anxiety and stress of an abnormal mammogram, so more women can enjoy the freedom of fewer benign biopsies. Enjoy the July 4th holiday! #BreastCancer #optoacoustic #ImagioImaging
-
-
Don’t miss it! Register now for the July 10th fireside chat with Tom Umbel, CEO, alongside market advisors from Frost & Sullivan, on Simplifying the Complexity of Diagnosing Breast Cancer, a casual discussion on the tools available to diagnose breast cancer and what is needed from technology. Sign up now at https://lnkd.in/gVKDqbTN #BreastCancer #optoacoustic #ImagioImaging
-
Seno University, led by breast ultrasound expert, Dr. Tom Stavros, accelerates adoption of Imagio® and quickly builds the confidence of imagers to begin assigning and down-grading BI-RADS. If you are ready to start talking about implementation at your facility, contact us at https://lnkd.in/gDzFmP85 #BreastCancer #optoacoustic #ImagioImaging
-
-
With real-time functional and anatomical images, Imagio® provides earlier diagnosis of malignancy and more confidence to differentiate cancers and benign masses. See how we’re giving radiologists more diagnostic confidence at: https://lnkd.in/gQYGfkDt #BreastCancer #optoacoustic #ImagioImaging
-
-
Don’t miss it! Register now for the July 10th fireside chat with Tom Umbel, CEO, alongside market advisors from Frost & Sullivan, on Simplifying the Complexity of Diagnosing Breast Cancer, a casual discussion on the tools available to diagnose breast cancer and what is needed from technology. Sign up now at https://lnkd.in/gBRUPwic #BreastCancer #optoacoustic #ImagioImaging
-
There are wide variations in the study of wait times to diagnose breast cancer after an abnormal mass, but compared to a real-time diagnostic tool like Imagio® anything over 1 day seems too long*. https://lnkd.in/gvEaWYir #BreastCancer #optoacoustic #ImagioImaging
-
Mark your calendars for live fireside chat with Tom Umbel, CEO, along with market advisors from Frost & Sullivan, on July 10. They’ll discuss the current landscape in breast cancer diagnostics and what it takes to launch a new modality. Register at https://lnkd.in/gzxZNzJ4 #BreastCancer #optoacoustic #ImagioImaging
-